Literature DB >> 33012270

Letter to the Editor: Toll-Like Receptor Antagonists as a Potential Therapeutic Strategy Against Cytokine Storm in COVID-19-Infected Patients.

Sadegh Safaei1,2,3, Masoud Karimi-Googheri1,2,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33012270     DOI： 10.1089/vim.2020.0074

Source DB:  PubMed          Journal:  Viral Immunol        ISSN： 0882-8245            Impact factor:   2.257


× No keyword cloud information.
  5 in total

Review 1.  Demyelination as a result of an immune response in patients with COVID-19.

Authors:  Zahra Shabani
Journal:  Acta Neurol Belg       Date:  2021-05-02       Impact factor: 2.471

2.  Why Females Do Better: The X Chromosomal TLR7 Gene-Dose Effect in COVID-19.

Authors:  Anna E Spiering; Teun J de Vries
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

3.  A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2.

Authors:  Ehsan Jahangirian; Ghadir A Jamal; MohammadReza Nouroozi; Alemeh Mohammadpour
Journal:  Immunogenetics       Date:  2021-09-20       Impact factor: 2.846

4.  COVID-19 susceptibility, severity, clinical outcome and Toll-like receptor (7) mRNA expression driven by TLR7 gene polymorphism (rs3853839) in middle-aged individuals without previous comorbidities.

Authors:  Sally M El-Hefnawy; Hanaa A Eid; Rasha G Mostafa; Shaimaa S Soliman; Thoria A Omar; Rania M Azmy
Journal:  Gene Rep       Date:  2022-04-18

Review 5.  Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond.

Authors:  Aileen Faist; Josua Janowski; Sriram Kumar; Saskia Hinse; Duygu Merve Çalışkan; Julius Lange; Stephan Ludwig; Linda Brunotte
Journal:  Cells       Date:  2022-07-14       Impact factor: 7.666
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.